Belatacept and mediastinal histoplasmosis in a kidney transplant patient

Hernán Trimarchi ¹ * , Tatiana Rengel ¹, José Andrews ¹, Matías Paulero ¹, Alejandro Iotti ², Agustina Forastiero ³, Fernando Lombi ¹, Vanesa Pomeranz ¹, Mariano Forrester ¹, Romina Iriarte ¹, Iris Agorio ³

Cited by CrossRef: 7

1- Gajurel K, Dhakal R, Deresinski S. Histoplasmosis in transplant recipients. Clinical Transplantation. 2017;31(10) [Crossref]

2- Zhao Y, Ye L, Zhao F, Zhang L, Lu Z, Chu T, Wang S, Liu Z, Sun Y, Chen M, Liao G, Ding C, Xu Y, Liao W, Wang L. Cryptococcus neoformans, a global threat to human health. Infect Dis Poverty. 2023;12(1) [Crossref]

3- Benamu E, Hogan C, Gomez C. Endemic Fungi in Transplant and Immunocompromised Hosts: Epidemiology, Diagnosis, Treatment, and Prevention. Curr Treat Options Infect Dis. 2020;12(1):30 [Crossref]

4- Zafar M, Rajan R, Ahmed R, Reddy A. Disseminated Histoplasmosis with Secondary Hemophagocytic Lymphohistiocytosis in a Renal Transplant Recipient on Belatacept-based Immunosuppression. 2024;3(3) [Crossref]

5- Abad C, Razonable R. Clinical Characteristics and Outcomes of Endemic Mycoses After Solid Organ Transplantation: A Comprehensive Review. 2024;11(3) [Crossref]

6- Bertrand D, Chavarot N, Gatault P, Garrouste C, Bouvier N, Grall-Jezequel A, Jaureguy M, Caillard S, Lemoine M, Colosio C, Golbin L, Rerolle J, Thierry A, Sayegh J, Etienne I, Lebourg L, Sberro R, Guerrot D. Opportunistic infections after conversion to belatacept in kidney transplantation. 2020;35(2):336 [Crossref]

7- Davis M, Thompson G, Patterson T. Fungal Infections Potentiated by Biologics. Infectious Disease Clinics of North America. 2020;34(2):389 [Crossref]